The Health Anxiety Inventory

1. Abstract

The Health Anxiety Inventory (HAI), specifically in its extensively validated 18-item short form known as the Short Health Anxiety Inventory (SHAI), is an empirically grounded, self-report psychometric instrument designed to evaluate the cognitive, affective, and behavioral manifestations of health anxiety and hypochondriasis independent of actual medical status. Developed by Paul M. Salkovskis, Kylie A. Rimes, H. M. C. Warwick, and David M. Clark (2002), the inventory was formulated to overcome the psychometric confound common to earlier somatic screening measures, which frequently conflated genuine physical symptomatology arising from organic medical conditions with psychological preoccupation and catastrophic interpretation. The SHAI consists of 18 multiple-choice vignettes or statement clusters, each scored on a 4-point ordinal metric ranging from 0 to 3, yielding a cumulative total score spanning 0 to 54. Structural evaluations consistently delineate a robust two-factor architecture comprising an Illness Likelihood subscale (Items 1 through 14), which indexes the perceived probability of developing or harboring a grave pathology alongside catastrophic rumination, and a Negative Consequences of Illness subscale (Items 15 through 18), which assesses anticipated distress, non-coping, and functional catastrophe conditional upon contracting a terminal or debilitating disease.

Extensive psychometric investigations across non-clinical, medical, and psychiatric populations demonstrate exceptional reliability and validity indices. Internal consistency estimates routinely satisfy rigorous psychometric standards, with Cronbach’s alpha coefficients ranging between .89 and .95 for the total scale, .85 to .92 for Illness Likelihood, and .70 to .86 for Negative Consequences. Test-retest reliability across intervals spanning two to twenty weeks demonstrates longitudinal stability (r = .87 to .90). Convergent validity is confirmed via robust correlations with correlated cognitive constructs, such as anxiety sensitivity (Anxiety Sensitivity Index), catastrophic misinterpretation of bodily sensations, and general anxiety symptoms (e.g., Beck Anxiety Inventory), while demonstrating discriminant divergence from major depressive symptom indices and objective physical illness severity. Sensitivity to treatment-induced change has been repeatedly documented across randomized controlled trials of cognitive behavioral therapy (CBT) and pharmacotherapy for Illness Anxiety Disorder and Somatic Symptom Disorder as codified within DSM-5. In sum, the SHAI represents the gold-standard psychometric benchmark in clinical health psychology and behavioral medicine for dissecting health-related catastrophic misinterpretations from baseline organic somatic conditions.

2. Keywords

Health Anxiety Inventory, Short Health Anxiety Inventory, SHAI, health anxiety, hypochondriasis, illness anxiety disorder, cognitive behavioral model, catastrophic misinterpretation, somatic symptom disorder, psychometrics, illness likelihood, negative consequences of illness, anxiety sensitivity, factor analysis

3. Authors

The Health Anxiety Inventory and its abbreviated variant were originated and validated by an international team of prominent clinical psychologists and psychopathology researchers:

• Paul M. Salkovskis, Ph.D., CPsychol, FBPsS — Professor of Clinical Psychology and Applied Science, Department of Psychology, University of Bath; previously at the Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King’s College London, and the University of Oxford Department of Psychiatry, United Kingdom. Primary investigator in the cognitive theory and treatment of health anxiety, obsessive-compulsive disorder, and panic disorder.
• Kylie A. Rimes, Ph.D. — Reader in Clinical Psychology, Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, United Kingdom. Expert in cognitive behavioral mechanisms in chronic fatigue syndrome, health anxiety, and affective dysregulation.
• H. M. C. Warwick, M.A., BM, BCh, FRCPsych — Consultant Psychiatrist and Senior Clinical Researcher, University of Oxford Department of Psychiatry, Warneford Hospital, Oxford, United Kingdom. Pioneer in cognitive behavioral therapies for severe hypochondriasis and somatic preoccupations.
• David M. Clark, D.Phil., FBA, FMedSci — Professor of Experimental Psychology, Department of Experimental Psychology, University of Oxford, United Kingdom; Co-founder of the UK Improving Access to Psychological Therapies (IAPT) initiative. Globally recognized authority on cognitive models of panic, social phobia, and hypochondriacal anxiety.

Correspondence regarding the original development of the instrument was historically directed through the Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, United Kingdom, and the Institute of Psychiatry, De Crespigny Park, Denmark Hill, London SE5 8AF, United Kingdom.

4. Purpose

The primary purpose of the Health Anxiety Inventory (HAI) is to deliver an empirically validated, clinically sensitive, and theoretically coherent metric designed to quantify the intensity of health-related anxiety, catastrophic illness appraisals, and hypochondriacal preoccupations across dimensional continua. Before the conception of the HAI, prevailing assessment instruments—including the Illness Attitude Scales (IAS) developed by Kellner and the Somatosensory Amplification Scale (SSAS) developed by Barsky—suffered from significant operational constraints. Most notably, legacy instruments frequently incorporated items indexing the subjective presence and frequency of baseline somatic sensations (e.g., muscle aches, palpitations, generalized fatigue, gastrointestinal discomfort). In clinical contexts characterized by comorbid physical medical conditions—such as cardiology, oncology, rheumatology, or neurology clinics—patients with authentic medical illnesses generated systematically elevated scores on these legacy scales solely due to the physical pathophysiology of their medical diagnoses, rather than any psychological propensity toward disproportionate health catastrophizing or abnormal illness behavior.

To eliminate this systematic confounding between genuine organic disease and psychological distress, Salkovskis and colleagues explicitly structured the HAI around cognitive and behavioral tenets derived from the cognitive model of health anxiety. Rather than inquiring whether a patient experiences specific physical symptoms, the HAI assesses the respondent’s cognitive appraisals, attentional fixation, interpretive biases, and catastrophic predictions regarding those bodily sensations, regardless of their medical etiology. By structuring questions in a conditional or interpretive format, the scale cleanly differentiates normative physical sensations from the pathological magnification of risk and perceived medical frailty.

In clinical practice, the SHAI serves diverse, vital functions across triage, diagnostic formulation, individualized case conceptualization, and empirical treatment monitoring. In mental health and psychiatric settings, it assists clinicians in operationalizing DSM-5 Illness Anxiety Disorder (formerly DSM-IV Hypochondriasis) and distressing variants of Somatic Symptom Disorder. It functions as an indispensable screening mechanism in primary care and general hospital settings, where patients with elevated health anxiety present disproportionately high utilization of medical procedures, diagnostic imaging, pathology investigations, and specialist referrals without experiencing enduring reassurance. In medical populations (e.g., patients recovering from myocardial infarction, patients undergoing cancer surveillance, or individuals managing autoimmune disorders), the SHAI allows behavioral medicine specialists to detect patients who exhibit disproportionate psychological morbidity relative to their actual physical pathology, facilitating early psychoeducational and cognitive behavioral interventions.

In empirical psychopathology research, the SHAI functions as an established primary endpoint measure in clinical trials evaluating cognitive behavioral therapies, acceptance-based paradigms, and psychopharmacological agents. Furthermore, the two-factor decomposition of the scale enables cognitive researchers to investigate distinct theoretical components of health-related anxiety: the subjective probability of contracting or possessing an illness versus the subjective awfulness and anticipated inability to tolerate its outcomes. This structural delineation aligns directly with contemporary formal models of anxiety, which conceptualize neurotic threat appraisal as the multiplicative product of likelihood and perceived severity, divided by perceived personal coping efficacy and external rescue factors.

5. Psychological Construct

The psychological construct evaluated by the Health Anxiety Inventory is health anxiety, conceptualized along a continuous, dimensional spectrum ranging from mild, transient, and evolutionarily adaptive bodily vigilance at one end, to debilitating, persistent, and functionally impairing hypochondriasis (or DSM-5 Illness Anxiety Disorder) at the other. Health anxiety is not merely the passive registration of bodily arousal; rather, it is a complex phenomenological triad consisting of cognitive biases, hypervigilant attentional allocation, and maladaptive compensatory behaviors centered around the perceived imminent threat of catastrophic physical disease.

Core Dimension 1: Illness Likelihood and Cognitive Preoccupation (Items 1–14)

The primary dimension of the SHAI encapsulates the respondent’s subjective estimate of the probability of currently harboring or subsequently developing a life-threatening or degenerative physical disease, alongside the cognitive and behavioral intrusions tied to that appraisal. Within this subscale, several interconnected cognitive-behavioral facets are measured:

• Bodily Hypervigilance and Selective Attention: Healthy somatic functioning involves constant autonomic, visceral, and musculoskeletal fluctuations that are ordinarily filtered out by sensory gating mechanisms. In elevated health anxiety, attentional resources are chronically diverted toward internal sensations. The individual engages in active scanning of the body, detecting minor physiological shifts (e.g., benign benign fasciculations, normative variations in pulse rate, transient dermatological changes) that would otherwise remain unnoticed.
• Catastrophic Misinterpretation of Benign Sensations: Once detected, normative physiological sensations or benign physical changes are interpreted through a negative cognitive filter as definitive indicators of virulent, progressive pathology. A transient tension headache is construed as an expanding glioblastoma; a harmless premature ventricular contraction is experienced as impending myocardial failure.
• Rumination and Cognitive Resistance Deficits: The intrusive contemplation of severe disease acquires an obsessional quality. Individuals experience difficulty disengaging from illness-related thoughts, experiencing failed attempts at mental suppression that paradoxically amplify intrusive thoughts through ironic cognitive rebound processes.
• Reassurance Seeking and Ephemeral Relief: A central behavioral hallmark captured in this dimension is the rapid decay of reassurance. When an authoritative medical professional conducts exhaustive objective diagnostics and confirms the absence of pathology, an individual with low or normative health anxiety experiences sustained relief. Conversely, an individual with pathological health anxiety experiences only transient, short-lived relief; within hours or days, doubt re-emerges (“What if the laboratory technician misread the blood smear?” “What if the scan missed an early lesion?”), driving further health-related checking, digital search queries (“cyberchondria”), or repeated medical consultations.
• Susceptibility to External Illness Cues: This facet captures heightened cognitive reactivity to external triggers, such as media reports of epidemics, health awareness campaigns, or hearing that an acquaintance has been diagnosed with a malignant illness. The individual reflexively internalizes these external cues, concluding that they are similarly vulnerable or already afflicted.

Core Dimension 2: Perceived Negative Consequences of Illness (Items 15–18)

The secondary dimension of the SHAI measures the respondent’s conditional appraisal of the anticipated burden, personal ruin, and catastrophic consequences should a serious illness be diagnosed. Unlike the first dimension, which captures the perceived likelihood of illness, this subscale explicitly instructs respondents to assume hypothetically that a serious disease has occurred, thereby assessing their beliefs regarding coping capacity, medical efficacy, emotional tolerance, and existential disruption:

• Anticipated Loss of Hedonic and Functional Capacity: Individuals scoring high on this dimension endorse beliefs that the diagnosis of a serious medical condition would utterly eliminate their capacity for pleasure, happiness, personal agency, or meaningful living, resulting in unmitigated despair and functional paralysis.
• Medical Hopelessness and Perceived Inefficacy of Intervention: This facet measures profound pessimism regarding therapeutic and medical interventions. The individual harbors underlying assumptions that modern medicine would prove incapable of providing remediation, symptom relief, or cure, regarding diagnosis as an irreversible death sentence.
• Erosion of Interpersonal Relations and Systemic Ruin: Catastrophic anticipation extends to social and systemic functioning, characterized by beliefs that severe disease would irrevocably ruin familial relationships, burden loved ones beyond endurance, and lead to total social isolation.
• Loss of Dignity and Subjective Integrity: The final facet indexes profound existential anxiety regarding the perceived destruction of personal dignity, autonomy, self-respect, and identity, viewing physical infirmity as inherently degrading and emotionally intolerable.

By measuring these two dimensions concurrently, the SHAI operationalizes the complete cognitive calculation underlying pathological somatic fear: elevating the subjective estimation of danger (Illness Likelihood) while simultaneously minimizing internal coping capacities and external medical resources (Negative Consequences).

6. Theoretical Framework

The theoretical architecture undergirding the Health Anxiety Inventory is firmly anchored in the cognitive behavioral model of health anxiety and hypochondriasis formulated by Salkovskis (1989), with direct theoretical continuity from the cognitive paradigms of Aaron T. Beck (1976) and David M. Clark’s cognitive formulation of panic disorder (1986). In Beck’s foundational cognitive theory of psychopathology, emotional distress is not elicited directly by external events or somatic sensations, but rather by the idiosyncratic, distorted cognitive schemas through which individuals interpret those experiences. Clark applied this principle to panic disorder, demonstrating that panic attacks arise when individuals catastrophically misinterpret benign autonomic sensations of arousal (such as tachycardia, lightheadedness, or shortness of breath) as immediate harbingers of imminent physical or mental catastrophe (such as dying of a heart attack, fainting, or going insane).

The Cognitive Formulation of Hypochondriasis (Salkovskis, 1989; Warwick & Salkovskis, 1990)

Salkovskis extended Clark’s paradigm to the understanding of persistent, chronic hypochondriacal preoccupations. While panic disorder involves the catastrophic misinterpretation of acute autonomic sensations as posing an immediate, second-by-second mortal danger, health anxiety involves the catastrophic misinterpretation of bodily signs, physical sensations, or medical information as signaling an insidious, progressive, and enduring disease process that threatens future wellbeing. The core cognitive equation formalized by Salkovskis dictates that the subjective perception of anxiety is governed by a mathematical appraisal ratio:

In this formulation, health anxiety escalates when the numerator expands (the individual believes that serious illness is highly probable and its consequences utterly intolerable) and the denominator contracts (the individual believes they possess zero resilience to cope with illness and that medicine will prove useless). The 18 items of the SHAI were engineered to evaluate both terms of this numerator-denominator dynamic: Items 1–14 assess the perceived probability of danger and obsessive preoccupation, whereas Items 15–18 evaluate the perceived catastrophic awfulness coupled with the collapse of coping and rescue potential.

The Self-Perpetuating Maintenance Cycle

According to Salkovskis and Warwick, once an individual activates dysfunctional illness schemas (often formed through early experiences of illness in oneself or significant others, medical traumas, or parental modeling of illness worry), a self-maintaining vicious circle is established:

1. Trigger: An internal trigger (a muscle twitch, mild lymph node enlargement, visceral discomfort) or external trigger (a cancer memorial, a medical television program, a pandemic news broadcast) activates core illness-related beliefs.
2. Cognitive Appraisal: The sensation is interpreted as catastrophic: “This tingling indicates the onset of multiple sclerosis.”
3. Emotional Response: The catastrophic appraisal immediately elicits physiological anxiety, activating sympathetic nervous system arousal (e.g., muscle tension, sweating, elevated heart rate, gastrointestinal hypermotility).
4. Somatic Amplification: Crucially, these physiological anxiety symptoms are misattributed by the patient as further physical evidence confirming the suspected pathology, triggering a positive feedback loop of somatic intensification.
5. Behavioral Coping and Safety Behaviors: In an effort to alleviate distress, the individual executes safety behaviors, including bodily checking (repeated palpation of lymph nodes, skin inspection), seeking reassurance from family or physicians, extensive internet research, or avoidance of physical exertion. While these behaviors are intended to neutralize threat, they invariably exacerbate the disorder: bodily checking increases local irritation and heightens sensory awareness; online searching yields catastrophic diagnostic possibilities; and reassurance seeking prevents cognitive reappraisal, reinforcing the underlying assumption that somatic sensations are dangerous until proven otherwise by medical certainty.

The SHAI measures the severity of these cognitive and behavioral loops, providing a direct metric of the degree to which an individual is trapped within this self-perpetuating cognitive maintenance cycle.

7. Validity

The Health Anxiety Inventory has been subjected to rigorous empirical psychometric validation across clinical, community, and medically diagnosed cohorts, establishing robust construct, convergent, discriminant, and predictive validity.

Construct and Factorial Validity

Construct validity was established in the original seminal investigations by Salkovskis, Rimes, Warwick, and Clark (2002). Using exploratory and confirmatory factor analytic methodologies across diverse samples—including patients meeting DSM-IV criteria for hypochondriasis, patients with clinical anxiety disorders, patients receiving treatment for general medical conditions, and non-clinical control participants—the scale exhibited a clean, theoretically congruent construct representation. Factor loadings for individual items consistently exceed .40 on their designated target dimensions. The theoretical two-factor construct has been replicated across numerous cross-cultural adaptations, including German, French, Spanish, Turkish, Italian, Chinese, and Scandinavian translations, confirming the universal factorial validity of the construct across varied health care systems and linguistic groups.

Convergent Validity

The SHAI exhibits strong, statistically significant convergent correlations with established measures evaluating health-related preoccupations, somatic awareness, and anxiety sensitivity. In the original validation studies (Salkovskis et al., 2002), the SHAI demonstrated high positive correlations with Kellner’s Illness Attitude Scales (IAS; r = .71 to .81) and the Somatosensory Amplification Scale (SSAS; r = .52 to .64). Strong convergence is also observed with the Anxiety Sensitivity Index (ASI; r = .55 to .68), reflecting the shared conceptual core of fear regarding bodily sensations. Correlations with generalized anxiety indices, such as the Beck Anxiety Inventory (BAI; r = .48 to .60) and the State-Trait Anxiety Inventory (STAI-Trait; r = .52 to .65), confirm that while the SHAI shares common variance with neuroticism and autonomic anxiety, it remains distinct from generalized, non-somatic worry.

Discriminant Validity

Discriminant validity is one of the most critical psychometric achievements of the SHAI. A major shortcoming of legacy hypochondriasis scales was their systematic failure to differentiate true physical pathology from hypochondriacal anxiety. Salkovskis et al. (2002) administered the SHAI to three distinct clinical cohorts: (a) patients with DSM-IV hypochondriasis, (b) patients diagnosed with confirmed, significant physical illness (such as severe renal failure requiring hemodialysis or chronic rheumatoid arthritis), and (c) healthy non-clinical controls. The findings revealed that patients with hypochondriasis scored markedly higher on the SHAI (Mean = 37.8, SD = 8.1) than patients with chronic organic physical medical illness (Mean = 15.2, SD = 6.4) and non-clinical controls (Mean = 12.0, SD = 5.2). Even though the medical illness group exhibited extensive real-world physical pathology, their SHAI scores remained indistinguishable from or only modestly elevated above healthy controls. This confirmed that the SHAI isolates cognitive catastrophizing and illness preoccupation without falsely penalizing individuals for objective organic disease.

Furthermore, while the SHAI correlates moderately with depressive indices (such as the Beck Depression Inventory-II; r = .35 to .50)—reflecting the well-known comorbidity between depressive distress and illness anxiety—multiple regression and structural equation modeling confirm that health anxiety remains factorially and predictively distinct from general dysphoria.

Predictive and Criterion Validity

The SHAI exhibits exceptional criterion-referenced validity in identifying clinical cases of hypochondriasis / DSM-5 Illness Anxiety Disorder. Receiver Operating Characteristic (ROC) analyses conducted across multiple clinical investigations demonstrate an Area Under the Curve (AUC) consistently ranging from .92 to .97. At an empirical cut-off score of 18 (or 20 depending on sample base rates), the SHAI achieves a sensitivity exceeding 85% and a specificity exceeding 87% in discriminating individuals meeting clinical diagnostic thresholds for hypochondriasis from those with non-clinical health worries or primary medical illnesses. Furthermore, the scale demonstrates robust predictive validity for objective health care utilization: higher baseline SHAI scores prospectively predict significantly greater numbers of primary care visits, emergency room attendances, diagnostic consultations, and unindicated laboratory requests over 12-month follow-up windows.

8. Reliability

The reliability of the Short Health Anxiety Inventory has been thoroughly demonstrated through evaluations of internal consistency, item-total correlations, split-half reliability, and test-retest temporal stability across diverse participant populations.

Internal Consistency

In the original scale development and psychometric evaluation conducted by Salkovskis et al. (2002), the 18-item SHAI exhibited high internal consistency across both non-clinical student samples and clinical cohorts. In a non-clinical cohort of 444 participants, the total scale achieved a Cronbach’s alpha of α = .89. In clinical cohorts presenting with hypochondriasis, the internal consistency reached α = .92 to .95. Evaluated at the subscale level, the Illness Likelihood factor (Items 1–14) demonstrates strong internal reliability, with alpha coefficients consistently spanning .85 to .92 across clinical and non-clinical samples. The Negative Consequences of Illness factor (Items 15–18), despite comprising only 4 items, demonstrates acceptable to good internal consistency, with alpha coefficients typically ranging between α = .70 and α = .86.

Subsequent international validation studies have consistently replicated these findings:

• Abramowitz, Deacon, and Valentiner (2007), examining a large North American undergraduate cohort (N = 685), reported a total SHAI alpha of α = .86, with α = .84 for Illness Likelihood and α = .74 for Negative Consequences.
• Alberts, Hadjistavropoulos, Jones, and Sharpe (2013), investigating clinical medical outpatients, recorded total scale alphas of α = .91.
• Cross-cultural translations, such as the Spanish validation (Lucock et al., 2015) and the Turkish adaptation (Aydemir et al., 2013), reported total Cronbach’s alphas of .88 and .91, respectively.

Corrected item-total correlations across the 18 items routinely exceed .40, with the majority falling between .50 and .72, indicating that each individual item contributes meaningfully to the overarching construct without redundant semantic overlap.

Test-Retest Stability

Temporal stability across non-intervention intervals confirms that the SHAI measures an enduring cognitive trait-like predisposition rather than mere fluctuating situational stress. In the original evaluation by Salkovskis et al. (2002), a subgroup of participants re-evaluated across a 2-week to 4-week interval yielded an intra-class test-retest correlation of r = .87 (p < .001). Abramowitz et al. (2007) reported a test-retest reliability coefficient of r = .89 across a 3-week test interval in a non-treatment cohort. Even over longer observation periods spanning 12 to 20 weeks in waitlist control groups participating in clinical treatment trials, SHAI scores remained remarkably stable (test-retest r values ranging from .82 to .88), while responding dynamically with large effect sizes (Cohen’s d > 1.2) following targeted cognitive-behavioral therapeutic protocols.

9. Factor Analysis

The latent structural organization of the Health Anxiety Inventory has been the subject of extensive empirical inquiry through both Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA).

Original Factor Structure (Salkovskis et al., 2002)

In the inaugural validation study, Salkovskis and colleagues performed principal components analysis (PCA) with oblimin oblique rotation on the 18 items of the abbreviated inventory. The analysis yielded a clean, interpretable two-factor solution accounting for substantial total variance:

• Factor 1: Illness Likelihood / Health Worry (Items 1–14): This dominant primary factor captures health anxiety, hypervigilance toward bodily sensations, difficulty resisting intrusive thoughts of illness, fear of acquiring disease, and rapid fading of medical reassurance. Factor loadings on this dimension ranged from .48 to .78, explaining the vast majority of the common variance.
• Factor 2: Negative Consequences of Illness (Items 15–18): This secondary factor cleanly segregated the four hypothetical items that evaluate the anticipated consequences should serious illness occur (inability to enjoy life, difficulty managing affairs, relationship disruption, and pervasive hopelessness). Loadings on this factor ranged from .55 to .82, with negligible cross-loadings onto Factor 1.

Confirmatory Structural Inquiries and Competing Models

Subsequent psychometric investigations have subjected the Salkovskis two-factor structure to rigorous CFA testing against alternative conceptual models. Abramowitz, Deacon, and Valentiner (2007) conducted CFA comparing three structural configurations:

1. A unidimensional single-factor model specifying all 18 items loading onto a single general health anxiety construct.
2. The original Salkovskis et al. oblique two-factor model (Factor 1: Items 1–14; Factor 2: Items 15–18).
3. A modified multi-factor model parsing Factor 1 into distinct cognitive-affective worry and behavioral avoidance/reassurance components.

The results decisively demonstrated the empirical superiority of the correlated two-factor model. Goodness-of-fit indices supported this specification, yielding a Comparative Fit Index (CFI) > .94, a Tucker-Lewis Index (TLI) > .93, and a Root Mean Square Error of Approximation (RMSEA) < .055 (with 90% confidence intervals between .045 and .062). The inter-factor correlation between Illness Likelihood and Negative Consequences was moderate (r = .42 to .54), confirming that while the two dimensions share common overarching variance related to threat appraisal, they capture distinct psychopathological processes.

Further structural evaluations (e.g., Alberts et al., 2013; Olatunji et al., 2011) have affirmed the stability of this two-factor model across non-clinical, anxiety disorder, and chronic pain cohorts. Measurement invariance testing across gender has established strict configural, metric, and scalar invariance, demonstrating that the SHAI measures the identical latent dimensions with equivalent psychometric precision in both men and women.

10. Instrument / Measurement Tool

The Short Health Anxiety Inventory (SHAI) is a self-administered, paper-and-pencil or digital questionnaire characterized by a multi-statement forced-choice format.

• Test Type: Self-report psychometric rating scale / dimensional screening inventory.
• Target Population: Adults and adolescents aged 16 and older across non-clinical community settings, psychiatric clinics, and medical inpatient/outpatient environments.
• Administration Time: Approximately 5 to 10 minutes.
• Item Composition: 18 multiple-choice clusters or vignettes. Each item consists of four graded statements representing escalating intensities of anxiety, attentional fixation, or perceived catastrophic impact over the preceding six months.
• Response Format: A 4-point ordinal choice per item, scored as:
  • (a) = 0
  • (b) = 1
  • (c) = 2
  • (d) = 3
• Scoring Procedures:
  • Total Score: Calculated by summing the numerical scores (0 through 3) selected across all 18 items. Theoretical range: 0 to 54.
  • Illness Likelihood Subscale (Core Health Anxiety): Sum of Items 1 through 14. Theoretical range: 0 to 42.
  • Negative Consequences of Illness Subscale: Sum of Items 15 through 18. Theoretical range: 0 to 12.
  • Reverse Scoring: There are no reverse-scored items. Every item is monotonically ordered such that option (a) represents minimal or normative health anxiety (0 points) and option (d) represents severe, pervasive hypochondriacal anxiety (3 points).
• Clinical Interpretation Guidelines:
  • 0 – 14: Normative / Low health anxiety. Typical of healthy community populations without disproportionate bodily concerns.
  • 15 – 19: Mild health anxiety. Noticeable bodily alertness or situational medical concern, but beneath standard thresholds for clinical intervention.
  • 20 – 27: Moderate health anxiety. Frequently indicates clinically elevated illness worry. Scores in this range warrant diagnostic appraisal for DSM-5 Illness Anxiety Disorder or Somatic Symptom Disorder.
  • 28 – 54: Severe health anxiety. Strongly indicative of severe, functionally debilitating hypochondriasis characterized by chronic hypervigilance, catastrophic appraisals, persistent reassurance seeking or total medical avoidance.
  • Empirical Cut-off: A score of 18 or above (or 20 in medical populations) is widely established in published literature as an optimal cut-off for identifying clinically significant health anxiety with optimized sensitivity and specificity.

11. Permissions & Fee and Test Year

The Short Health Anxiety Inventory (SHAI) was published in its definitive psychometric form in 2002 by Paul M. Salkovskis, Kylie A. Rimes, H. M. C. Warwick, and David M. Clark in the peer-reviewed journal Psychological Medicine (Cambridge University Press). The instrument was developed within academic research institutions (the University of Oxford and King’s College London) funded by public research bodies, including the Wellcome Trust and the Medical Research Council (MRC).

Licensing and Fee Status: The SHAI is widely classified as an open-access psychometric instrument for academic research, education, and routine non-commercial clinical practice. No commercial royalty fees or formal purchase requirements are mandated for academic researchers or individual clinicians administering the instrument for diagnostic or treatment outcome evaluation. However, the original publications remain under the copyright of the authors and Cambridge University Press. Reproduction, widespread commercial software distribution, or modification within proprietary digital assessment platforms typically requires formal permission from the copyright holders or primary author (Prof. Paul M. Salkovskis). Clinicians and researchers utilizing the scale are obligated to cite the seminal 2002 validation paper in all clinical reports, theses, and published literature.

12. References

• Abramowitz, J. S., Deacon, B. J., & Valentiner, D. P. (2007). The Short Health Anxiety Inventory: Psychometric properties and construct validity in a non-clinical sample. Cognitive Therapy and Research, 31(6), 871–883. https://doi.org/10.1007/s10608-006-9058-1
• Alberts, N. M., Hadjistavropoulos, H. D., Jones, S. L., & Sharpe, D. (2013). The Short Health Anxiety Inventory: A systematic review and meta-analysis of its psychometric properties. Journal of Anxiety Disorders, 27(2), 221–237. https://doi.org/10.1016/j.janxdis.2013.01.003
• Aydemir, Ö., Kirpinar, I., Sati, T., Uykur, B., & Ceylan, E. (2013). Reliability and validity of the Turkish version of the Short Health Anxiety Inventory. Archives of Neuropsychiatry, 50(4), 325–331. https://doi.org/10.4274/npa.y6562
• Barsky, A. J., & Wyshak, G. (1990). Hypochondriasis and somatosensory amplification. British Journal of Psychiatry, 157(S8), 58–64. https://doi.org/10.1192/S000712500029188X
• Beck, A. T. (1976). Cognitive therapy and the emotional disorders. International Universities Press.
• Clark, D. M. (1986). A cognitive approach to panic. Behaviour Research and Therapy, 24(4), 461–470. https://doi.org/10.1016/0005-7967(86)90011-2
• Kellner, R. (1986). Somatization and hypochondriasis. Praeger-Greenwood.
• Lucock, M., Morley, S., White, C., & Peake, M. D. (2015). Responses of health anxious patients to reassurance: An empirical study. British Journal of Health Psychology, 20(3), 541–556. https://doi.org/10.1111/bjhp.12120
• Olatunji, B. O., Deacon, B. J., Abramowitz, J. S., & Valentiner, D. P. (2011). Body vigilance in nonclinical and anxiety disorder samples: Structure, specificity, and related increments. Journal of Psychopathology and Behavioral Assessment, 33(3), 390–400. https://doi.org/10.1007/s10862-011-9226-5
• Salkovskis, P. M. (1989). Somatic problems. In K. Hawton, P. M. Salkovskis, J. Kirk, & D. M. Clark (Eds.), Cognitive behaviour therapy for psychiatric problems: A practical guide (pp. 235–276). Oxford University Press.
• Salkovskis, P. M., Rimes, K. A., Warwick, H. M. C., & Clark, D. M. (2002). The Health Anxiety Inventory: Development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychological Medicine, 32(5), 843–853. https://doi.org/10.1017/s0033291702005822
• Warwick, H. M. C., & Salkovskis, P. M. (1990). Hypochondriasis. Behaviour Research and Therapy, 28(2), 105–117. https://doi.org/10.1016/0005-7967(90)90023-C

13. Items of the Scale (Questionnaire)